PULMONX CORPORATION - COMMON STOCK

Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference

20 11 2024 16:05:00 提供 Nasdaq GlobeNewswire

Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

07 11 2024 16:05:01 提供 Nasdaq GlobeNewswire

Pulmonx to Present at the Stifel 2024 Healthcare Conference

05 11 2024 16:05:00 提供 Nasdaq GlobeNewswire

Pulmonx Reports Third Quarter 2024 Financial Results

30 10 2024 16:05:00 提供 Nasdaq GlobeNewswire

Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024

16 10 2024 16:05:00 提供 Nasdaq GlobeNewswire

Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024

09 9 2024 16:05:00 提供 Nasdaq GlobeNewswire

Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference

29 8 2024 16:05:00 提供 Nasdaq GlobeNewswire

Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference

22 8 2024 16:05:00 提供 Nasdaq GlobeNewswire

Pulmonx Reports Second Quarter 2024 Financial Results

31 7 2024 16:05:00 提供 Nasdaq GlobeNewswire

Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference

29 7 2024 16:05:00 提供 Nasdaq GlobeNewswire

Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024

10 7 2024 16:05:00 提供 Nasdaq GlobeNewswire

Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

06 5 2024 17:03:06 提供 Nasdaq GlobeNewswire

Pulmonx Reports First Quarter 2024 Financial Results

01 5 2024 16:05:00 提供 Nasdaq GlobeNewswire

Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024

10 4 2024 16:05:00 提供 Nasdaq GlobeNewswire

Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer

02 4 2024 16:05:00 提供 Nasdaq GlobeNewswire

Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

15 3 2024 17:00:37 提供 Nasdaq GlobeNewswire

Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results

21 2 2024 16:06:00 提供 Nasdaq GlobeNewswire

Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer

21 2 2024 16:05:00 提供 Nasdaq GlobeNewswire

Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024

07 2 2024 16:05:00 提供 Nasdaq GlobeNewswire

Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference

15 11 2023 16:05:00 提供 Nasdaq GlobeNewswire